19 Nov 2020

COVID-19 vaccine: the top runners and riders

From Nine To Noon, 9:34 am on 19 November 2020
Pfizer and BioNTech Announce Successful First Interim Analysis of their COVID-19 Vaccine Candidate in Current Phase 3 Trial

Photo: AFP

The latest developments in the multiple candidates for a COVID-19 vaccine, with the University of Otago's Professor David Murdoch, a clinical microbiologist who's consulted for the WHO and the Health's Ministry Covid-19 Technical Advisory Group.

He's also been formally supporting the Oxford University COVID-19 vaccine development effort.

This follows promising results from two different vaccines ( one from Pfizer, the other Moderna) in as many weeks, which were both found to be highly effective in late stage trials.

Get the RNZ app

for easy access to all your favourite programmes

Subscribe to Nine To Noon

Podcast (MP3) Oggcast (Vorbis)